Weight Loss News and Research RSS Feed - Weight Loss News and Research

Results from Intarcia's two phase 3 clinical trials of ITCA 650 to be presented at ADA's Scientific Session

Results from Intarcia's two phase 3 clinical trials of ITCA 650 to be presented at ADA's Scientific Session

Intarcia Therapeutics, Inc. today announced the presentation of results from its first two phase 3 clinical trials (FREEDOM-1 and FREEDOM-1 HBL) of its late-stage investigational candidate ITCA 650 (exenatide delivered continuously via a small matchstick-size subcutaneous osmotic mini-pump just once or twice yearly) at the 75th Scientific Sessions of the American Diabetes Association. [More]
New statistics show oesophageal cancer rates increase by 50% in men

New statistics show oesophageal cancer rates increase by 50% in men

Oesophageal cancer rates in men have increased by 50 per cent since the early 1980s, with new cases reaching almost 6,000, according to new statistics from Cancer Research UK. [More]
Gastrostomy methods equivalent in amyotrophic lateral sclerosis

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

The ProGas study results show that three methods of gastrostomy are equally good in terms of complications and survival in patients with amyotrophic lateral sclerosis. [More]
Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity. [More]
Low-cost, non-profit weight loss program offers long-term results

Low-cost, non-profit weight loss program offers long-term results

As America's obesity epidemic continues to grow, a new study from the University of Colorado Anschutz Medical Campus shows that a low-cost, non-profit weight loss program offers the kind of long-term results that often elude dieters. [More]
Maternal obesity increases health risks for mothers and their babies

Maternal obesity increases health risks for mothers and their babies

Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London. [More]
Hi-Tech Pharmaceuticals signs definitive agreement to acquire FormuTech Nutrition

Hi-Tech Pharmaceuticals signs definitive agreement to acquire FormuTech Nutrition

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and FormuTech Nutrition, one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire FormuTech. [More]
Bariatric surgery leads to greater intimacy between patients and their life partners

Bariatric surgery leads to greater intimacy between patients and their life partners

Bariatric surgery does not only benefit the health of patients who undergo this weight loss procedure. It also leads to greater intimacy between them and their life partners, and adds a spark to their sex life. It's all in all a shared journey that brings partners closer together, says Mary Lisa Pories of East Carolina University in the US, lead author of a study providing insights into the experience of couples after one of the partners underwent weight loss surgery. [More]
Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures. [More]
Zinc levels linked to formation of kidney stone

Zinc levels linked to formation of kidney stone

New research on kidney stone formation reveals that zinc levels may contribute to kidney stone formation, a common urinary condition that can cause excruciating pain. The research found that zinc may be the core by which stone formation starts. [More]
Plastic surgeries in the US surge due to increase in weight loss surgeries

Plastic surgeries in the US surge due to increase in weight loss surgeries

An increase in the number of weight loss surgeries in the U.S. is beginning to have a ripple effect in plastic surgery, according to new data released today by the American Society of Plastic Surgeons (ASPS). Procedures specifically associated with massive weight loss, including tummy tucks, thigh lifts, breast lifts and upper arm lifts, grew at their fastest rate in four years in 2014, according to the report. That follows a similar increase in the growth of weight loss surgeries. [More]
Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

CTI BioPharma Corp. and Baxter International's Bioscience business today announced data from PERSIST-1 – a randomized Phase 3 registration-directed trial examining pacritinib for the treatment of myelofibrosis – in a late-breaking oral session at the 51st Annual Meeting of the American Society of Clinical Oncology, May 29-June 2, 2015 in Chicago, Ill. [More]
WHO report: Percentage of obese population set to rise in European nations

WHO report: Percentage of obese population set to rise in European nations

Although the dangers of obesity have become increasingly clear in recent years, new research from the World Health Organization suggests that the number of people who are obese around the world will only increase. The most recent report analyzed all of the European nations and concluded that the percentage of obese citizens is set to rise in nearly every country. [More]
Modest lifestyle changes help breast cancer survivors lose weight

Modest lifestyle changes help breast cancer survivors lose weight

Carrying extra body fat increases the risk for diabetes, heart disease and stroke, and also increases risk of cancer recurrence after a breast cancer diagnosis. A multi-institutional study presented at the American Society for Clinical Oncology Annual Meeting 2015 shows that female breast cancer survivors are able to lose weight through modest lifestyle changes. [More]
New hope for patients suffering from most severe forms of anorexia nervosa

New hope for patients suffering from most severe forms of anorexia nervosa

Anorexia Nervosa has the highest mortality rate of any mental illness. In its most severe form, victims face a devastating 4,500% increased risk for death. In the wake of the recent national attention on the limited treatment options available for these extreme cases, it is important for sufferers to know that help is available. [More]
Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015. [More]
GHIT Fund expands investments in leishmaniasis, diagnostic tests

GHIT Fund expands investments in leishmaniasis, diagnostic tests

The Global Health Innovative Technology Fund, which in the last two years has funded almost $32 million for innovative tools to tackle global infectious diseases, today announced additional investments of nearly $11 million that bring its portfolio to approximately $43 million. [More]
Splicing pattern of obesity, type 2 diabetes genes may contribute to pathophysiology of obesity

Splicing pattern of obesity, type 2 diabetes genes may contribute to pathophysiology of obesity

Alternative splicing of obesity and type 2 diabetes related genes may contribute to the pathophysiology of obesity, according to research from the University of Eastern Finland. Obesity leads to changes in the splicing pattern of metabolically relevant genes such as TCF7L2 and INSR, resulting in impaired insulin action. [More]
Weight loss can improve outcomes in lung transplant patients

Weight loss can improve outcomes in lung transplant patients

Obesity is a complicating factor for many surgical patients. In a recent study published in the Journal of Heart and Lung Transplantation, Mayo Clinic researchers have shown that losing weight can have a positive impact on outcomes for lung transplant patients. [More]
UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19. [More]
Advertisement
Advertisement